Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Hair root sheaths are more common in non-scarring hair loss and help diagnose the type of hair loss.

Dense-packing follicular unit extraction is a safe and effective way to treat extensive scarring alopecia.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

Combining FUE hair transplantation with PRP improves hair density and patient satisfaction in scarring alopecia.

Autologous follicular stem cells improved hair loss in 57% of patients.

Follicular microautotransplantation effectively improves scalp scars and enhances quality of life.

Hair follicle bumps with stem cells might contribute to permanent hair loss by getting disconnected due to scarring.

The absence of functional sebaceous glands causes hair follicle destruction and scarring alopecia.

Keratosis Pilaris Atrophicans causes skin scarring and might be treated with a new synthetic retinoid.

FUE provides minimal scarring and quick recovery in hair transplantation, and surgeons not using it may lag in technology.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

A mother and daughter had severe skin, hair, and eye issues linked to IFAP.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

A woman with long-term scalp psoriasis developed rare scarring hair loss that didn't fully respond to treatments.

EVG staining helps tell apart follicular scars from follicular streamers, aiding in diagnosing different types of hair loss.

FUE can be successfully done on African-American hair by using larger punch tools and careful techniques to reduce hair damage.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Exosome therapy shows promise for treating hair loss but needs more research and standardization.

Caffeine therapy helped hair recovery after chemical and traction damage.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Choosing between follicular unit extraction and strip harvesting for hair restoration depends on the patient's individual goals and the pros and cons of each method.

A rare scalp condition, cutis verticis gyrata, was found in a woman with primary scarring alopecia.

Improving donor scar appearance in hair transplants involves careful technique and addressing factors like tension, scalp elasticity, and patient habits.

Trichoscopy is effective for diagnosing different types of non-scarring hair loss.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Loss of oil glands and inflammation might contribute to the development of scarring hair loss.

KFSD is a rare condition causing scarring hair loss, with no effective treatment known at the time of the report.